转化毒理学:综合研究策略的发展焦点。

IF 2.9 3区 医学 Q2 Medicine
Claude Hughes, Michael Waters, David Allen, Iyabo Obasanjo
{"title":"转化毒理学:综合研究策略的发展焦点。","authors":"Claude Hughes, Michael Waters, David Allen, Iyabo Obasanjo","doi":"10.1186/2050-6511-14-51","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Given that toxicology studies the potential adverse effects of environmental exposures on various forms of life and that clinical toxicology typically focuses on human health effects, what can and should the relatively new term of \"translational toxicology\" be taken to mean?</p><p><strong>Discussion: </strong>Our assertion is that the core concept of translational toxicology must incorporate existing principles of toxicology and epidemiology, but be driven by the aim of developing safe and effective interventions beyond simple reduction or avoidance of exposure to prevent, mitigate or reverse adverse human health effects of exposures.The field of toxicology has now reached a point where advances in multiple areas of biomedical research and information technologies empower us to make fundamental transitions in directly impacting human health. Translational toxicology must encompass four action elements as follows: 1) Assessing human exposures in critical windows across the lifespan; 2) Defining modes of action and relevance of data from animal models; 3) Use of mathematical models to develop plausible predictions as the basis for: 4) Protective and restorative human health interventions. The discussion focuses on the critical window of in-utero development.</p><p><strong>Summary: </strong>Exposure assessment, basic toxicology and development of certain categories of mathematical models are not new areas of research; however overtly integrating these in order to conceive, assess and validate effective interventions to mitigate or reverse adverse effects of environmental exposures is our novel opportunity. This is what we should do in translational toxicology so that we have a portfolio of interventional options to improve human health that include both minimizing exposures and specific preventative/restorative/mitigative therapeutics.</p>","PeriodicalId":48846,"journal":{"name":"BMC Pharmacology & Toxicology","volume":"14 ","pages":"51"},"PeriodicalIF":2.9000,"publicationDate":"2013-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/2050-6511-14-51","citationCount":"1","resultStr":"{\"title\":\"Translational toxicology: a developmental focus for integrated research strategies.\",\"authors\":\"Claude Hughes, Michael Waters, David Allen, Iyabo Obasanjo\",\"doi\":\"10.1186/2050-6511-14-51\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Given that toxicology studies the potential adverse effects of environmental exposures on various forms of life and that clinical toxicology typically focuses on human health effects, what can and should the relatively new term of \\\"translational toxicology\\\" be taken to mean?</p><p><strong>Discussion: </strong>Our assertion is that the core concept of translational toxicology must incorporate existing principles of toxicology and epidemiology, but be driven by the aim of developing safe and effective interventions beyond simple reduction or avoidance of exposure to prevent, mitigate or reverse adverse human health effects of exposures.The field of toxicology has now reached a point where advances in multiple areas of biomedical research and information technologies empower us to make fundamental transitions in directly impacting human health. Translational toxicology must encompass four action elements as follows: 1) Assessing human exposures in critical windows across the lifespan; 2) Defining modes of action and relevance of data from animal models; 3) Use of mathematical models to develop plausible predictions as the basis for: 4) Protective and restorative human health interventions. The discussion focuses on the critical window of in-utero development.</p><p><strong>Summary: </strong>Exposure assessment, basic toxicology and development of certain categories of mathematical models are not new areas of research; however overtly integrating these in order to conceive, assess and validate effective interventions to mitigate or reverse adverse effects of environmental exposures is our novel opportunity. This is what we should do in translational toxicology so that we have a portfolio of interventional options to improve human health that include both minimizing exposures and specific preventative/restorative/mitigative therapeutics.</p>\",\"PeriodicalId\":48846,\"journal\":{\"name\":\"BMC Pharmacology & Toxicology\",\"volume\":\"14 \",\"pages\":\"51\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2013-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1186/2050-6511-14-51\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMC Pharmacology & Toxicology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/2050-6511-14-51\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Pharmacology & Toxicology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/2050-6511-14-51","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

摘要

背景:鉴于毒理学研究环境暴露对各种生命形式的潜在不利影响,而临床毒理学通常侧重于对人类健康的影响,“转化毒理学”这个相对较新的术语可以而且应该被理解为什么意思?讨论:我们的主张是,转化毒理学的核心概念必须纳入现有的毒理学和流行病学原则,但应以制定安全有效的干预措施为目标,而不是简单地减少或避免接触,以预防、减轻或逆转接触对人类健康的不利影响。毒理学领域现在已经达到这样一个阶段,生物医学研究和信息技术的多个领域的进展使我们能够在直接影响人类健康方面作出根本转变。翻译毒理学必须包括以下四个行动要素:1)评估人类在整个生命周期的关键窗口期的暴露;2)定义动物模型数据的作用方式和相关性;3)利用数学模型发展合理的预测,作为以下方面的基础:4)保护性和恢复性人类健康干预措施。讨论的重点是子宫内发育的关键窗口。摘要:暴露评估、基础毒理学和某些类别数学模型的发展并不是新的研究领域;然而,为了构思、评估和验证有效的干预措施,以减轻或逆转环境暴露的不利影响,公开整合这些因素是我们的新机会。这是我们在转化毒理学中应该做的,这样我们就有了一系列的干预选择来改善人类健康,包括尽量减少暴露和特定的预防/恢复/缓解治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Translational toxicology: a developmental focus for integrated research strategies.

Background: Given that toxicology studies the potential adverse effects of environmental exposures on various forms of life and that clinical toxicology typically focuses on human health effects, what can and should the relatively new term of "translational toxicology" be taken to mean?

Discussion: Our assertion is that the core concept of translational toxicology must incorporate existing principles of toxicology and epidemiology, but be driven by the aim of developing safe and effective interventions beyond simple reduction or avoidance of exposure to prevent, mitigate or reverse adverse human health effects of exposures.The field of toxicology has now reached a point where advances in multiple areas of biomedical research and information technologies empower us to make fundamental transitions in directly impacting human health. Translational toxicology must encompass four action elements as follows: 1) Assessing human exposures in critical windows across the lifespan; 2) Defining modes of action and relevance of data from animal models; 3) Use of mathematical models to develop plausible predictions as the basis for: 4) Protective and restorative human health interventions. The discussion focuses on the critical window of in-utero development.

Summary: Exposure assessment, basic toxicology and development of certain categories of mathematical models are not new areas of research; however overtly integrating these in order to conceive, assess and validate effective interventions to mitigate or reverse adverse effects of environmental exposures is our novel opportunity. This is what we should do in translational toxicology so that we have a portfolio of interventional options to improve human health that include both minimizing exposures and specific preventative/restorative/mitigative therapeutics.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
BMC Pharmacology & Toxicology
BMC Pharmacology & Toxicology PHARMACOLOGY & PHARMACY-TOXICOLOGY
CiteScore
4.40
自引率
0.00%
发文量
0
审稿时长
12 weeks
期刊介绍: BMC Pharmacology and Toxicology is an open access, peer-reviewed journal that considers articles on all aspects of chemically defined therapeutic and toxic agents. The journal welcomes submissions from all fields of experimental and clinical pharmacology including clinical trials and toxicology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信